222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details


臨床試験数 : 285 薬物数 : 300 - (DrugBank : 108) / 標的遺伝子数 : 61 - 標的パスウェイ数 : 190

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03095118
(ClinicalTrials.gov)
September 7, 201720/3/2017Daratumumab in Treatment of PGNMID and C3 GNSingle-center Phase 2 Open-label Trial Evaluating Efficacy and Safety of Daratumumab in Treatment of Patients With Proliferative Glomerulonephritis With Monoclonal Immune Deposits and C3 Glomerulopathy Associated With Monoclonal GammopathyMembranoproliferative GlomerulonephritisDrug: DaratumumabFernando FervenzaNULLActive, not recruiting18 YearsN/AAll10Phase 2United States